Close Menu

NEW YORK (GenomeWeb) – GenMark Diagnostics said today that it has received US Food and Drug Administration 510(k) clearance for its ePlex Blood Culture Identification Gram-Positive (BCID-GP) Panel.

The firm had announced toward the end of June that it applied to the FDA for market clearance.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Vox writes that lab mishaps involving pathogens are quite common.

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.